mirtazapine has been researched along with Constipation in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Constipation: Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gambi, F | 1 |
De Berardis, D | 1 |
Campanella, D | 1 |
Carano, A | 1 |
Sepede, G | 1 |
Salini, G | 1 |
Mezzano, D | 1 |
Cicconetti, A | 1 |
Penna, L | 1 |
Salerno, RM | 1 |
Ferro, FM | 1 |
Bremner, JD | 1 |
2 trials available for mirtazapine and Constipation
Article | Year |
---|---|
Mirtazapine treatment of generalized anxiety disorder: a fixed dose, open label study.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety Disorders; Appetite; Constipation; Female; Humans; | 2005 |
A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Constipation; Depressive Disorder; Double-Blind Met | 1995 |